Related Experiment Video

Updated: Mar 28, 2026

Controllable Ion Channel Expression through Inducible Transient Transfection
10:00

Controllable Ion Channel Expression through Inducible Transient Transfection

Published on: February 17, 2017

10.0K

Human transient receptor potential (TRP) channel expression profiling in carcinogenesis

Michela Bernardini1, Alessandra Fiorio Pla, Natalia Prevarskaya

  • 1University Lille, U1003 - PHYCEL - Physiologie Cellulaire, Lille, France.

The International Journal of Developmental Biology
|December 19, 2015
PubMed

Insights

Transient Receptor Potential (TRP) channels are vital in cancer development. A comprehensive understanding of TRP channel "transportomes" is needed for effective anti-cancer therapies and clinical markers.

Area of Science:

  • Ion channel research
  • Molecular oncology
  • Carcinogenesis

Background:

  • Transient Receptor Potential (TRP) cation channels are implicated in cancer hallmarks like proliferation and angiogenesis.
  • Despite decades of research, a complete profile of TRP channel involvement in cancer is lacking.
  • Current studies often examine TRP channels in isolation, hindering therapeutic development.

Purpose of the Study:

  • To review existing literature on TRP channel expression profiles in carcinogenesis.
  • To highlight the need for a complete TRP signature for targeted cancer therapies.
  • To explore methods for achieving a full TRP expression profile in cancer.

Main Methods:

  • Literature review of studies on TRP channels and cancer.
  • Analysis of partial TRP expression profiles in various cancer stages.
  • Discussion of methodologies for comprehensive TRP profiling.

Main Results:

  • Partial TRP expression profiles have been identified in the literature.
  • TRP channel activity is essential for key cancer processes.
  • A holistic view of TRP channels is required for clinical applications.

Conclusions:

  • TRP channels represent promising targets for anti-cancer drug development.
  • A complete TRP signature is crucial for advancing cancer diagnostics and therapeutics.
  • Further research is needed to integrate individual TRP channel knowledge into a comprehensive cancer transportome.

More Related Videos

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV412:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.7K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K

Related Concept Videos

Thermosensation01:43

Thermosensation

Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
35.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K